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Abstract
A reagentless glutamate biosensor was applied to the determination of glutamate released from liver hepatocellular carcinoma cells (HepG2) in response to toxic challenge from various concentrations of paracetamol. A screen printed carbon electrode (SPCE) containing the electrocatalyst Meldola's Blue (MB-SPCE) served as the electron mediator for the oxidation of NADH.
A mixture of the enzyme glutamate dehydrogenase (GLDH), cofactor nicotinamide adenine dinucleotide (NAD + ) and the biopolymer chitosan (CHIT) were drop-coated onto the surface of the transducer (MB-SPCE) in a simple one step fabrication process.
The reagentless biosensor was used with amperometry in stirred solution at an applied potential of +0.1 V (vs. Ag/AgCl). All experiments were carried out at the following conditions: pH 7, temperature 37ºC, atmosphere 5% CO 2 .
The linear range of the device was found to be 25 -125 μM in phosphate buffer (75 mM, containing 0.05 M NaCl) and 25 -150 μM in cell culture medium. The limits of detection (LOD) were found to be 1.2 µM and 4.2 µM based on three times signal to noise, using PBS and culture medium respectively. The sensitivity was calculated to be 106 nA µM -1 cm -2 and 210 nA µM -1 cm -2 in PBS and cell medium respectively. The response time was ~60s in an agitated solution.
HepG2 cells were exposed to various concentrations of paracetamol (1 mM, 5 mM and 10 mM) in order to investigate the drug-induced release of glutamate into the culture medium in real time. Two toxicity studies were investigated using different methods of exposure and analysis.
The first method consisted of a single measurement of the glutamate concentration, using the method of standard addition, after 24 hours incubation. The concentrations of glutamate were
Introduction
Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous system [1] and also has a central role in cell metabolism and function [2] . Glutamate is associated with processes such as protein synthesis/degradation, ammonia disposal, energy production and neurotransmission [3] , thus glutamate plays a significant role in fundamental metabolic processes. As a result, glutamate is present in many cells such as skeletal muscle, liver, intestine and kidneys. Specifically, glutamate plays vital roles in hepatic metabolic pathways such as ureagenesis, gluconeogenesis and glutathione synthesis [4] .
The concentration of intracellular glutamate is typically higher than that of extracellular glutamate. For example, within the brain, extracellular glutamate concentrations are normally within the 1 -10 µM range [5, 6] whilst intracellular glutamate concentrations are typically in the micromolar range [7] . Similar micromolar levels have been observed intracellularly in rat livers [8, 9] .
Drug discovery is a costly and extensive process, with product development comprising up to 30 -35% of the cost of bringing a new pharmaceutical compound to the market [10] . Early candidates for drug development are selected based on their pharmacological and toxicological properties which are investigated through early-stage in vitro cell-based assays [11] . Cytotoxicity assays such as neutral red, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), LDH (lactate dehydrogenase) leakage, and protein assays are commonly used to evaluate the effects of drugs on cell metabolism and death [12] . However, these are employed by sampling off-line, or as end-point assays, and do not provide information on early toxicity events in real-time. In an approach using electrochemical biosensors to address the issue of continuous analyte monitoring in vitro, Pemberton et. al. [13, 14] have described the development and application of a screen-printed microband biosensor to follow glucose uptake by HepG2 cells in the presence of different concentrations of paracetamol.
Some reports have described the use of chitosan for the immobilization of glutamate dehydrogenase on glassy carbon [15] [16] [17] [18] , gold [19] and platinum [20] electrodes. Both reagentless and non-reagentless conventional sized glutamate biosensors have previously been developed by drop-coating the required biomolecules onto the working electrode of a screen-printed carbon electrode [21] [22] [23] . We have recently reviewed electrochemical glutamate biosensor construction and their applications in food and clinical analysis [24] .
Modified Chitosan has been utilised for the covalent immobilization of glutamate oxidase [25] and lactate oxidase [26] , however, as far as we are aware, there are no examples of the use of chitosan to fabricate screen-printed microband glutamate biosensors. In this paper we explore this latter possibility and demonstrate the application of the proposed device for realtime monitoring of toxicity, through the metabolic changes (glutamate release) caused by the addition of paracetamol. ethanol was diluted with cell culture media and filtered sterilised (0.2µm) before use.
Materials and Methods

Chemicals and Reagents
Apparatus
All electrochemical experiments were conducted with a two electrode system consisting of a carbon working electrode containing MB (MB-SPCE, Gwent Electronic Materials Ltd; Ink Code: C2030519P5), and a Ag/AgCl reference electrode (The difference between the screenprinted Ag/AgCl electrode and the conventional Ag/AgCl (3M NaCl) was +80mV) (GEM Product Code C61003P7); both printed onto PVC (poly vinyl chloride). The electrodes were connected to the potentiostat using gold clips. Microband electrodes/biosensors and reference electrodes were held by gold clips attached to cork lids which were push-fitted into 6-well plate wells (Corning®). Electrodes were connected to a PG580RM 5-channel potential (Uniscan Instruments Ltd, Buxton, UK; www.uniscan.com) which was controlled using UiEChem software (Version 2.02), for both single and multiple parallel well experiments. All cell culture work and dosing with paracetamol was conducted under a sterile conditions. The cork lid electrode holders was sterilised with 70% ethanol spray. The electrodes themselves
were not sterilised as the ethanol would potentially damage the enzyme and cofactor.
Experiments utilising culture medium and HepG2 cells were carried out in an incubator with a 5% CO 2 atmosphere at 37ºC in order to maintain the correct pH. Sonications were performed with a Devon FS100 sonicator (Ultrasonics, Hove, Sussex, UK).
Principle of operation of the biosensor
The overall principle of operation of the biosensor is shown in Figure 1 . Glutamate in solution is oxidised to form 2-oxoglutarate in the presence of the immobilised enzyme glutamate dehydrogenase (GLDH) and NAD + ; the products NADH and NH 4 + are formed during this reaction. NADH chemically reduces Meldola's Blue which subsequently undergoes electrochemical oxidation at the electrode surface to produce the analytical response.
Biosensor Fabrication
The fabrication procedure is illustrated in Figure 2 . Five microliters of CHIT (0.05% in 0.05M HCl) were drop-coated onto the surface of a 3 mm 2 working electrode (a), followed by 9µL of GLDH (3U/µL) and 1µL of NAD + (106µg) (b). The biosensor was then left to dry overnight at 4ºC (c). Once dried, insulating tape was used to cover the working area and some of the electrode track (d). Microbiosensors were formed by cutting through the working electrode using scissors to expose a 3mm-long working electrode edge (e).
Electron Microscopy
The microband biosensor was attached to a 9 mm-diameter double sided adhesive carbon disc on a 45º angled aluminium stub. A cross section of the edge of the electrode was examined using a Philips XL30 environmental scanning electron microscope (ESEM).
HepG2 cell culture
The HepG2 (Human Caucasian Hepatocyte Carcinoma) cell line (obtained from European
Collection of Authenticated Cell Cultures, ECACC) was cultured as a monolayer in 75 cm 2 flasks, in a 5% CO 2 -in-air atmosphere at 37 °C, at an initial density of 2 x10 5 cells cm −2 .
Cells were counted using a haemocytometer. The culture medium was EMEM containing 10% FBS, 1% non-essential amino acids (NEAA), 200 nM L-glutamine. When confluent, the cells were detached by trypsinisation, and resuspended in culture medium. For the assays described, cells were plated at a density of 2 x 10 6 cells mL −1 in 6 mL volumes into 6-well tissue culture plates.
Voltammetry and amperometry
All cyclic voltammetric studies were carried out by lowering a microband biosensor, in combination with a screen-printed Ag/AgCl reference electrode, into the voltammetric cell containing a 10 ml solution of 75 mM phosphate containing 50 mM NaCl (PBS). For studies with NADH, the following procedure was employed: phosphate buffer solution was carried out in the presence and absence of oxygen, followed by 15s equilibration at open circuit voltage. The working electrode potential scanned from an initial potential of -0.5 V to the switching potential, +0.6V, at a scan rate of 5 mVs -1 .
All of the studies involved the use of six-well plates containing appropriate control or test solutions which were agitated using a gyrorotator at a fixed speed which ensured thorough mixing of the cells with paracetamol. Gyrorotation of the plates was maintained for the duration of the experiments. All amperometric measurements were carried using an applied potential of +0.1V. A calibration study was performed using culture media. Additions of glutamate were made so that the final concentrations in the solution were in the range of 25 -150µM. All studies were carried out at pH 7.4.
Real-time monitoring of glutamate in cell culture medium in the presence/absence of cells and toxic compounds.
HepG2 cells grown in T75 flasks, once 80% confluent were trypsinized and transferred to six well tissue culture plates, along with 6mls of cell medium under sterile conditions. 24 hours were allowed to pass to allow the cells to fully adhere to the bottom of the wells. Appropriate aliquots of paracetamol (from 100 mM in 20% ethanol, diluted with cell culture medium)
were then exchanged for medium in order to achieve the desired final concentrations in a 6ml volume. The cork lids which held the microband glutamate biosensor and reference electrode were push-fitted into each well. A small (1 mm diameter) hole in the top surface of each sensor cork lid allowed air to escape, avoided pressure build-up during the push-fitting step and allowed for gaseous exchange to maintain the pH of the media.
The electrode leads were extended from the inside of the incubator through the temperature seal and connected to respective channels of the multichannel potentiostat. The 6-well plate was rotated utilising a gyro-rotator within an incubator at 37 °C, 5% CO 2 in the air
atmosphere. An operating potential of +0.1 V vs Ag/AgCl was applied to each working electrode, and the instrument was run in amperometric mode for 8 hours for the real-time experiments. The resulting data were exported into Microsoft Excel and plotted as currentversus-time graphs.
Results and Discussion
Microband Biosensor
An SEM image of the edge of a microband biosensor is shown in Fig 3. The image is labelled to indicate the layers of the individual components. The thickness of the original Meldola's Blue screen printed working electrode was 20 µm. The area of the exposed edge of the microband electrode was 60,000 µm 2 (3 mm x 20 µm).
Cyclic voltammetric behaviour of NADH using a microband biosensor.
Cyclic voltammograms were obtained with the microband biosensors in a solution containing NADH, 75 mM PBS pH 7; a scan rate of 5 mVs -1 was used. Typical cyclic voltammetric responses for NADH are shown in Fig 4. The spikes present on the voltammogram arise from the silver redox reaction due to the silver contained within the ink. In the presence of NADH the responses show sigmoidal and steady state behaviour; these show that an increase in the anodic peak potential occurred with increasing concentrations of NADH. This behaviour is indicative of the electro-catalytic oxidation of NADH [27] and is a pre-requisite for applications in monitoring glutamate.
The steady state currents resulting from this electrocatalytic behaviour are obtained for both deoxygenated ( Figure 4 ) and oxygenated (Supp Figure 1) solutions of NADH and are very similar. It may also be noted, at a voltage of +0.5V, there is an observed rise in the anodic current, this arises owing to the potential being sufficiently positive to cause the direct oxidation of NADH at the carbon particles of the modified screen printed electrode. We have observed this second oxidation in previous work for NADH at MB-SPCE [27] . It appears that although small cathodic peaks appear in Figure 4 , they are considerably smaller in the absence of oxygen compared to those in the presence of oxygen. This is clearer by referring to the blank red CV (oxygen present) compared to the blue CV (oxygen absent). This we believe can be explained by the presence of a small concentration of residual oxygen in the solution, following the deoxygenation procedure. An applied potential of +0.1V was chosen for the operation of the biosensor, in order to avoid oxidising interferences that may be present within complex cell media.
3.3.
Calibration studies of glutamate in cell culture medium using a microband biosensor and operational stability. linear range, 25 -150 µM; sensitivity, 0.13 nA/µM; and a theoretical limit of detection of 4.24 µM (based on three times signal to noise). At this point the biosensor assay appears to be suitable for our proposed real time cell toxicity studies.
The operational stability of the biosensor was investigated over a period of 8 hours. The microband biosensor was inserted into an agitated cell media solution containing 100µM of glutamate and after steady state had been reached an aliquot of paracetamol (10mM) was added to the solution. Supplementary Figure 2 demonstrates that the addition of paracetamol does not influence the magnitude of the glutamate response over a period of 8 hours. This observation is important for the studies described in the following sections (3.4/3.5).
Glutamate determination in cell culture medium after 24 hours' exposure of
HepG2 cells to various concentrations of paracetamol.
Fully confluent HepG2 cells were exposed to various concentrations of paracetamol (1 mM, 5 mM and 10 mM) for 24 hours. After exposure, the cell medium was collected and the cells were disposed of. The microband biosensor was initially immersed in untreated cell medium, and once a steady-state baseline was achieved the biosensor was transferred to the postexposure cell media. This resulted in an increase in current as a result of the additional glutamate released by the HepG2 cells. Once steady-state had been reached, standard additions of 25 mM glutamate were added to the cell. The response generated by the endogenous glutamate present in the cell medium and the additions of glutamate were plotted against concentration. From this standard addition plot, the original concentration of glutamate found in the cell media was determined.
The average endogenous concentrations for glutamate released from the HepG2 cells were 52 µM (CoV: 13.74%, n = 3), 93 µM (CoV: 18.41%, n = 3) and 177 µM (CoV: 14.54% n = 3) for 1 mM, 5 mM, 10 mM doses of paracetamol respectively. A bar chart (Fig 6) illustrates the relationship between increasing paracetamol concentration, and increased release of glutamate. The data shown for each concentration of paracetamol is based on the determination of the glutamate concentration released into the culture medium of three separately treated flasks of HepG2. The standard deviations shown are based on n = 3.
Real-time monitoring of glutamate release from HepG2 cells exposed to various concentrations of paracetamol.
Fully confluent HepG2 cells in six well plates were incubated with various concentrations of paracetamol (1 mM, 5 mM and 10 mM) as described above. Microband biosensors were placed into the wells within 5 minutes of paracetamol addition; the release of glutamate was then monitored in real time over an 8 hour period at the applied potential of +0.1V. Figure 7 illustrates an example of the currents generated as a result of glutamate released from the Clearly, the increase in the current due to the release of glutamate correlates with the increasing paracetamol concentration. The mechanism behind the release of glutamate is likely to be due to the Phase I and Phase II metabolism of paracetamol by the enzyme CYP450 present within HepG2 cells. CYP450 typically converts paracetamol to the toxic byproduct N-acetyl-p-benzoquinone imine (NAPQI). At sub-lethal concentrations of paracetamol, glutathione conjugates the NAPQI to a non-harmful product. However, at higher doses of paracetamol the glutathione is unable to regenerate sufficiently to process the NAPQI [28] . NAPQI subsequently binds to membrane proteins [29] [30], resulting in hepatic necrosis, which leads to the rupture of the cell membrane and release of its contents. With increasing concentrations of paracetamol, the number of liver cells undergoing hepatic necrosis will increase, resulting in the release of glutamate from the cells. The extent to which the glutamate is released scales accordingly with the increasing concentrations of paracetamol metabolised by the cells.
The advantage of monitoring the cells in real time is that it is possible to determine the length of time taken for the paracetamol to have an effect upon the metabolism of the HepG2 cells.
As shown in Fig. 7 , it appears to take 1 hour (3600s) for glutamate to begin to be released from the cells and this timing seems to be independent of the drug concentration. The average timing for the glutamate release is as follows (n = 3); 1mM -2916s, 5mM -2666 s and 10mM -3566 s. After 7 hours the currents begin to reach steady state, suggesting that the release of glutamate from the cells has ceased.
Conclusions
This paper has described the successful development and application of an amperometric, reagentless, glutamate microband biosensor. We believe that this is achieved by a combination of mainly crosslinking and partial entrapment of the biocomponents onto the surface of the working electrode using the biopolymer, chitosan. The former occurs through interaction of the amine groups of chitosan with the carboxyl groups of glutamate dehydrogenase; a similar suggestion has been made by Baker et.al [31] . The entrapment process is likely to involve partial diffusion of the enzyme/cofactor layer into the chitosan layer, which subsequently forms a hydro-gel. It should be mentioned that in the absence of chitosan on the surface of the biosensor, non-steady-state currents were obtained in response to additions of glutamate ( Supp Fig 3. ). This may be attributed to the poor immobilization of the enzyme/cofactor on the surface of the screen-printed electrode and highlights the importance of the chitosan layer.
The device has been successfully applied to the determination of glutamate released by 
